[Our clinical experience with a new lytic mixture associated with rupture of the membranes in labor:  efosin and dihydroergotamine].
D002317:Cardiovascular Agents; D004087:Dihydroergotamine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007751:Labor, Induced; D007743:Labor, Obstetric; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010120:Oxytocics; D011247:Pregnancy
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D009125:Muscle Relaxants, Central; D010120:Oxytocics; D004087:Dihydroergotamine
ERGOT ALKALOIDS/therapeutic use; LABOR, INDUCED; MUSCLE RELAXANTS/therapeutic use
Nuestra experiencia clinica con una nueva mezcla litica asociada con la rotura de la bolsa en el parto:  efosina y dihidroergotamina.